These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33662501)

  • 1. The distinct roles of monoamines in multiple sclerosis: A bridge between the immune and nervous systems?
    Carandini T; Cercignani M; Galimberti D; Scarpini E; Bozzali M
    Brain Behav Immun; 2021 May; 94():381-391. PubMed ID: 33662501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of brainstem monoaminergic fibre tracts in multiple sclerosis as a putative mechanism for cognitive fatigue: a fixel-based analysis.
    Carandini T; Mancini M; Bogdan I; Rae CL; Barritt AW; Sethi A; Harrison N; Rashid W; Scarpini E; Galimberti D; Bozzali M; Cercignani M
    Neuroimage Clin; 2021; 30():102587. PubMed ID: 33610097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamines: Dopamine, Norepinephrine, and Serotonin, Beyond Modulation, "Switches" That Alter the State of Target Networks.
    Azizi SA
    Neuroscientist; 2022 Apr; 28(2):121-143. PubMed ID: 33292070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature.
    Roelands B; Meeusen R
    Sports Med; 2010 Mar; 40(3):229-46. PubMed ID: 20199121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of monoaminergic neurotransmitters in thermoregulation.
    Zeisberger E
    Can J Physiol Pharmacol; 1987 Jun; 65(6):1395-401. PubMed ID: 2887271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain.
    Bravo L; Llorca-Torralba M; Berrocoso E; Micó JA
    Front Neurosci; 2019; 13():1268. PubMed ID: 31942167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoaminergic mechanisms of stimulation-produced analgesia.
    Akil H; Liebeskind JC
    Brain Res; 1975 Aug; 94(2):279-96. PubMed ID: 125141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diethylation labeling combined with UPLC/MS/MS for simultaneous determination of a panel of monoamine neurotransmitters in rat prefrontal cortex microdialysates.
    Ji C; Li W; Ren XD; El-Kattan AF; Kozak R; Fountain S; Lepsy C
    Anal Chem; 2008 Dec; 80(23):9195-203. PubMed ID: 19551941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
    Sartori DP; Oliveira NF; Valentim JT; Silva DMA; Mallman ASV; Oliveira ICM; Chaves RC; Capibaribe VC; Carvalho AMR; Rebouças MO; Macedo DS; Chaves Filho AJM; Fonteles MMF; Gutierrez SJC; Barbosa-Filho JM; Mottin M; Andrade CH; Sousa FCF
    Behav Brain Res; 2020 Apr; 383():112487. PubMed ID: 31987932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature.
    Moll JL; Brown CS
    J Sex Med; 2011 Apr; 8(4):956-70. PubMed ID: 21272265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamines stimulate sex reversal in the saddleback wrasse.
    Larson ET; Norris DO; Gordon Grau E; Summers CH
    Gen Comp Endocrinol; 2003 Feb; 130(3):289-98. PubMed ID: 12606271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodining: Common dietary factors may be substrates in novel biosynthetic pathways for monoaminergic neurotransmitters.
    Fitzgerald PJ
    Med Hypotheses; 2020 May; 138():109618. PubMed ID: 32070787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine modulation of tonic GABAA inhibition.
    Crunelli V; Di Giovanni G
    Rev Neurosci; 2014; 25(2):195-206. PubMed ID: 24468610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.
    Melnikov M; Rogovskii V; Boykо A; Pashenkov M
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):37-47. PubMed ID: 31011885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
    Pifl C; Schingnitz G; Hornykiewicz O
    Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology to functionality: the brain and neurotransmitter activity.
    Racagni G; Brunello N
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 1():S3-7. PubMed ID: 10468322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.
    Svob Strac D; Pivac N; Smolders IJ; Fogel WA; De Deurwaerdere P; Di Giovanni G
    Front Neurosci; 2016; 10():492. PubMed ID: 27891070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoaminergic Modulation of Motor Cortex Function.
    Vitrac C; Benoit-Marand M
    Front Neural Circuits; 2017; 11():72. PubMed ID: 29062274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.